{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:33:09Z","timestamp":1788582789058,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"MSD Bulgaria"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14228-3","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T10:43:37Z","timestamp":1756291417000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Bulgarian exploratory analysis of time from diagnosis to treatment of lung cancer patients (Beat) - a retrospective database study on the patient pathway and time from diagnosis to treatment"],"prefix":"10.1186","volume":"25","author":[{"given":"Assen","family":"Dudov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolay","family":"Conev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mila","family":"Petrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Tonev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Nacheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria V.","family":"Dimitrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Dimitrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"key":"14228_CR1","unstructured":"Global cancer observatory. Cancer today. Globocan: 2022: Bulgaria. Available at: https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/populations\/100-bulgaria-fact-sheet.pdf. Accessed on: March 2024."},{"issue":"2","key":"14228_CR2","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3904\/kjim.2020.030","volume":"35","author":"HJ Park","year":"2020","unstructured":"Park HJ, Lee SH, Chang YS. Recent advances in diagnostic technologies in lung cancer. Korean J Intern Med. 2020;35(2):257\u201368. https:\/\/doi.org\/10.3904\/kjim.2020.030.","journal-title":"Korean J Intern Med"},{"key":"14228_CR3","doi-asserted-by":"publisher","unstructured":"Krzyszczyk P, Acevedo A, Davidoff EJ, Timmins LM, Marrero-Berrios I, Patel M, White C, Lowe C, Sherba JJ, Hartmanshenn C, O\u2019Neill KM, Balter ML, Fritz ZR, Androulakis IP, Schloss RS, Yarmush ML. The growing role of precision and personalized medicine for cancer treatment. Technology (Singap world Sci). 2018 Sep-Dec;6(3\u20134):79\u2013100. https:\/\/doi.org\/10.1142\/S2339547818300020","DOI":"10.1142\/S2339547818300020"},{"key":"14228_CR4","doi-asserted-by":"publisher","first-page":"998222","DOI":"10.3389\/fonc.2022.998222","volume":"12","author":"J Liao","year":"2023","unstructured":"Liao J, Li X, Gan Y, Han S, Rong P, Wang W, Li W, Zhou L. Artificial intelligence assists precision medicine in cancer treatment. Front Oncol. 2023;12:998222. https:\/\/doi.org\/10.3389\/fonc.2022.998222.","journal-title":"Front Oncol"},{"issue":"1","key":"14228_CR5","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1080\/13102818.2021.1903338","volume":"35","author":"P Maria Dimitrova","year":"2021","unstructured":"Maria Dimitrova P, Milushewa E, Petrova D, Mihaylova NT, Guenka Petrova. Triple negative breast cancer in Bulgaria: epidemiological data and treatment patterns based on real world evidence and patient registries. Biotechnol Biotechnol Equip. 2021;35(1):551\u20139. https:\/\/doi.org\/10.1080\/13102818.2021.1903338.","journal-title":"Biotechnol Biotechnol Equip"},{"key":"14228_CR6","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s12254-015-0214-8","volume":"8","author":"Z Mihaylova","year":"2015","unstructured":"Mihaylova Z, Megdanova V, Petrova V, et al. Lung cancer in Bulgaria \u2013 diagnosis, treatment, and factors affecting survival. Memo. 2015;8:136\u201343. https:\/\/doi.org\/10.1007\/s12254-015-0214-8.","journal-title":"Memo"},{"issue":"3","key":"14228_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.canep.2015.03.015","volume":"39","author":"N Dimitrova","year":"2015","unstructured":"Dimitrova N, Parkin DM. Data quality at the Bulgarian National Cancer registry: an overview of comparability, completeness, validity and timeliness. Cancer Epidemiol. 2015;39(3):405\u201313. https:\/\/doi.org\/10.1016\/j.canep.2015.03.015.","journal-title":"Cancer Epidemiol"},{"key":"14228_CR8","doi-asserted-by":"crossref","unstructured":"Petrov M, Dimitrova M, Mitkova Z. Feasibility study on the possibilities for implementation of National screen program for lung Cancer in CEE countries with focus on the Balkan region value in health, 27, Issue 12, S291.","DOI":"10.1016\/j.jval.2024.10.1508"},{"key":"14228_CR9","doi-asserted-by":"publisher","unstructured":"Rohova M. Regional imbalances in distribution of Bulgarian health professionals. J of IMAB. 2017 Jan-Mar;23(1):1427\u201331. https:\/\/doi.org\/10.5272\/jimab.2017231.1427","DOI":"10.5272\/jimab.2017231.1427"},{"issue":"8","key":"14228_CR10","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.3390\/cancers16081489","volume":"16","author":"K Kostadinov","year":"2024","unstructured":"Kostadinov K, Popova-Sotirova I, Marinova Y, Musurlieva N, Iskrov G, Stefanov R. Availability and access to orphan drugs for rare cancers in Bulgaria: analysis of delays and public expenditures. Cancers (Basel). 2024;16(8):1489. https:\/\/doi.org\/10.3390\/cancers16081489.","journal-title":"Cancers (Basel)"},{"key":"14228_CR11","unstructured":"ESMO: COUNTRY PROFILE: CANCER MEDICINES SHORTAGES BULGARIA. Available at: https:\/\/www.esmo.org\/content\/download\/197318\/3552932\/1\/ESMO-Country-profile-Bulgaria.pdf. Accessed on: March 2025."},{"issue":"4","key":"14228_CR12","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3390\/ijerph15040577","volume":"15","author":"K Osowiecka","year":"2018","unstructured":"Osowiecka K, Rucinska M, Nowakowski JJ, Nawrocki S. How long are Cancer patients waiting for oncological therapy in Poland? Int J Environ Res Public Health. 2018;15(4):577. https:\/\/doi.org\/10.3390\/ijerph15040577.","journal-title":"Int J Environ Res Public Health"},{"issue":"8","key":"14228_CR13","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.3390\/ijerph17082837","volume":"17","author":"T Holecki","year":"2020","unstructured":"Holecki T, W\u0119grzyn M, Fr\u0105czkiewicz-Wronka A, Sobczyk K. Oncological diseases and social costs considerations on undertaken health policy interventions. Int J Environ Res Public Health. 2020;17(8):2837. https:\/\/doi.org\/10.3390\/ijerph17082837.","journal-title":"Int J Environ Res Public Health"},{"key":"14228_CR14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1475-9276-8-44","volume":"8","author":"BA Kuchinke","year":"2009","unstructured":"Kuchinke BA, Sauerland D, W\u00fcbker A. The influence of insurance status on waiting times in German acute care hospitals: an empirical analysis of new data. Int J Equity Health. 2009;8:44. https:\/\/doi.org\/10.1186\/1475-9276-8-44.","journal-title":"Int J Equity Health"},{"issue":"1","key":"14228_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41533-024-00359-w","volume":"34","author":"I Tsiligianni","year":"2024","unstructured":"Tsiligianni I, Christodoulakis A, Monastirioti A, Mavroudis D, Agelaki S. The journey of lung cancer patients from symptoms to diagnosis in Greece. A mixed methods approach. NPJ Prim Care Respir Med. 2024;34(1):5. https:\/\/doi.org\/10.1038\/s41533-024-00359-w.","journal-title":"NPJ Prim Care Respir Med"},{"issue":"2","key":"14228_CR16","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3897\/pharmacia.68.e64931","volume":"68","author":"I Tsekov","year":"2021","unstructured":"Tsekov I, Dimitrova M, Voynikov Y. Role of the EMA specific marketing authorization procedures for early access on the time to patient access in Bulgaria. Pharmacia. 2021;68(2):421\u20135. https:\/\/doi.org\/10.3897\/pharmacia.68.e64931.","journal-title":"Pharmacia"},{"issue":"5","key":"14228_CR17","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/ijc.34753","volume":"154","author":"JM Vancoppenolle","year":"2024","unstructured":"Vancoppenolle JM, Franzen N, Koole SN, Ret\u00e8l VP, van Harten WH. Differences in time to patient access to innovative cancer medicines in six European countries. Int J Cancer. 2024;154(5):886\u201394. https:\/\/doi.org\/10.1002\/ijc.34753.","journal-title":"Int J Cancer"},{"issue":"13","key":"14228_CR18","doi-asserted-by":"publisher","first-page":"11849","DOI":"10.1007\/s00432-023-05062-w","volume":"149","author":"C Roderburg","year":"2023","unstructured":"Roderburg C, Loosen SH, Leyh C, Joerdens MS, Mohr R, Luedde T, Alymova S, Klein I, Kostev K. Prevalence of and factors associated with a treatment delay due to the COVID-19 pandemic in patients with Gastrointestinal cancer in Europe. J Cancer Res Clin Oncol. 2023;149(13):11849\u201356. https:\/\/doi.org\/10.1007\/s00432-023-05062-w. https:\/\/ec.europa.eu\/commission\/presscorner\/detail\/en\/SPEECH_20_195. Accessed on February 2024.","journal-title":"J Cancer Res Clin Oncol"},{"key":"14228_CR19","unstructured":"https:\/\/ec.europa.eu\/commission\/presscorner\/detail\/en\/SPEECH_20_195. Accessed on February 2024."},{"issue":"5","key":"14228_CR20","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.21037\/tlcr-20-890","volume":"10","author":"JP van Meerbeeck","year":"2021","unstructured":"van Meerbeeck JP, Franck C. Lung cancer screening in Europe: where are we in 2021? Transl Lung Cancer Res. 2021;10(5):2407\u201317. https:\/\/doi.org\/10.21037\/tlcr-20-890.","journal-title":"Transl Lung Cancer Res"},{"key":"14228_CR21","doi-asserted-by":"publisher","DOI":"10.1787\/health_glance-2017-en","volume-title":"Health at a glance 2017: OECD indicators","author":"OECD","year":"2017","unstructured":"OECD. Health at a glance 2017: OECD indicators. Paris: OECD Publishing; 2017. https:\/\/doi.org\/10.1787\/health_glance-2017-en."},{"issue":"2","key":"14228_CR22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.healthpol.2004.07.003","volume":"72","author":"L Siciliani","year":"2005","unstructured":"Siciliani L, Hurst J. Tackling excessive waiting times for elective surgery: a comparative analysis of policies in 12 OECD countries. Health Policy. 2005;72(2):201\u201315. https:\/\/doi.org\/10.1016\/j.healthpol.2004.07.003.","journal-title":"Health Policy"},{"key":"14228_CR23","unstructured":"Hanning M. Maximum waiting-time guarantee \u2014 a remedy to long waiting lists? Assessment of the Swedish waiting-time guarantee policy 1992\u20131996. Acta Universitatis Upsaliensis; 2005. 106 p."},{"issue":"1\u20132","key":"14228_CR24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.healthpol.2013.06.013","volume":"112","author":"N Viberg","year":"2013","unstructured":"Viberg N, Forsberg BC, Borowitz M, Molin R. International comparisons of waiting times in health care\u2013limitations and prospects. Health Policy. 2013;112(1\u20132):53\u201361. https:\/\/doi.org\/10.1016\/j.healthpol.2013.06.013.","journal-title":"Health Policy"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14228-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14228-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14228-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T10:43:40Z","timestamp":1756291420000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14228-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14228"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14228-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,27]]},"assertion":[{"value":"19 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. The data collection and analysis scope excluded safety and patient involvement reconciliation; therefore, informed ethical permission was not required for the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1384"}}